Patent Execution Strategies
Nanopharmaceutical & Drug Delivery Research Lab (NDDRL), Faculty of Pharmacy, Integral University, Lucknow 226 060, Uttar Pradesh
- *Corresponding Author:
- Md. Faiyazuddin
Assistant Professor & Principle Investigator
Nanopharmaceutical & Drug Delivery Research Lab (NDDRL)
Faculty of Pharmacy, Integral University
Kursi Road, Lucknow 226060
Uttar Pradesh, INDIA
E-mail: [email protected]; [email protected]
Received Date: December 26, 2013; Accepted Date: December 26, 2013; Published Date: December 31, 2013
Citation: Faiyazuddin Md. (2013) Patent Execution Strategies. Intel Prop Rights 2:e102. doi: 10.4172/2375-4516.1000e102
Copyright: © 2013 Faiyazuddin Md. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Patents are considered to be enticements for innovation and thereby expected to benefit humanity by making available to the society. Pharmaceutical patents cover products that take a very long time to develop and the patent life is actually closer to 11 or 12 years since federal law requires a company to test its product for safety and efficacy and secure regulatory approval before marketing. Developing countries experience shows that such incentives focus on the market demand rather than the need of the society. This is more obvious in the health related innovation. Therefore, a strong IP protections safeguard should be held against counterfeit, illegitimate and fake pharmaceutical products.